306 related articles for article (PubMed ID: 15093603)
1. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property.
Charnay C; Bégu S; Tourné-Péteilh C; Nicole L; Lerner DA; Devoisselle JM
Eur J Pharm Biopharm; 2004 May; 57(3):533-40. PubMed ID: 15093603
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
3. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
4. Potential of amorphous microporous silica for ibuprofen controlled release.
Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
[TBL] [Abstract][Full Text] [Related]
5. Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery.
Tang Q; Xu Y; Wu D; Sun Y; Wang J; Xu J; Deng F
J Control Release; 2006 Aug; 114(1):41-6. PubMed ID: 16784793
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen.
Yang YJ; Tao X; Hou Q; Chen JF
Acta Biomater; 2009 Nov; 5(9):3488-96. PubMed ID: 19442764
[TBL] [Abstract][Full Text] [Related]
7. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
8. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
9. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.
Yang P; Quan Z; Lu L; Huang S; Lin J
Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic property measurement of surfactant-templated mesoporous silica films using time-resolved single-molecule imaging.
Kennard R; DeSisto WJ; Giririjan TP; Mason MD
J Chem Phys; 2008 Apr; 128(13):134710. PubMed ID: 18397097
[TBL] [Abstract][Full Text] [Related]
11. Polymer-mesoporous silica materials templated with an oppositely charged surfactant/polymer system for drug delivery.
Lin H; Zhu G; Xing J; Gao B; Qiu S
Langmuir; 2009 Sep; 25(17):10159-64. PubMed ID: 19552374
[TBL] [Abstract][Full Text] [Related]
12. Gas adsorption in mesoporous micelle-templated silicas: MCM-41, MCM-48, and SBA-15.
Coasne B; Galarneau A; Di Renzo F; Pellenq RJ
Langmuir; 2006 Dec; 22(26):11097-105. PubMed ID: 17154590
[TBL] [Abstract][Full Text] [Related]
13. A magnetic, luminescent and mesoporous core-shell structured composite material as drug carrier.
Yang P; Quan Z; Hou Z; Li C; Kang X; Cheng Z; Lin J
Biomaterials; 2009 Sep; 30(27):4786-95. PubMed ID: 19520428
[TBL] [Abstract][Full Text] [Related]
14. Effective controlled release of captopril by silylation of mesoporous MCM-41.
Qu F; Zhu G; Huang S; Li S; Qiu S
Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
[TBL] [Abstract][Full Text] [Related]
15. Ibuprofen loading in surfactant-templated silica: role of the solvent according to the polarizable continuum model.
Fernández-Núñez M; Zorrilla D; Montes A; Mosquera MJ
J Phys Chem A; 2009 Oct; 113(42):11367-75. PubMed ID: 19780578
[TBL] [Abstract][Full Text] [Related]
16. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
17. Release evaluation of drugs from ordered three-dimensional silica structures.
Izquierdo-Barba I; Martinez A; Doadrio AL; Pérez-Pariente J; Vallet-Regí M
Eur J Pharm Sci; 2005 Dec; 26(5):365-73. PubMed ID: 16185852
[TBL] [Abstract][Full Text] [Related]
18. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release.
Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A
J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
Rehman F; Rahim A; Airoldi C; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
[TBL] [Abstract][Full Text] [Related]
20. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
